Abstract

Artificial intelligence (AI) is revolutionizing cancer research and tailored medical care at a significant speed. AI is a generic concept related to making use of computer as a medium to mimic intellectual actions to accomplish complex activities with limited human interference, like deep neural networks and machine learning. Availability of high-dimensionality datasets coupled with advancements in high-performance computing and novel deep learning techniques are leading to an explosion of AI use in numerous aspects of cancer research. The current drug discovery is making use of AI technology, such as machine learning. AI has a significant ability to improve health maintenance services in fields such as risk identification, diagnostics, lifestyle supervision, health records administration, and virtual health care. As far as different treatment methodologies are concerned, AI is utilized to evaluate immunological signatures, medical imagery, and histological analyses of treatment responses. AI has a significant impact on practically every area of oncology from improving diagnosis to tailoring treatment and identifying new anticancer medications. This chapter explores advancements in artificial information technology, such as machine learning and deep learning, in anticancer research. At the same time, one can look forward to AI's expectations.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.